These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 8037915

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
    Luan FL, Steffick DE, Ojo AO.
    Transplantation; 2011 Feb 15; 91(3):334-41. PubMed ID: 21242885
    [Abstract] [Full Text] [Related]

  • 64. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
    Eason JD, Loss GE, Blazek J, Nair S, Mason AL.
    Liver Transpl; 2001 Aug 15; 7(8):693-7. PubMed ID: 11510013
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Long-term immunosuppression after liver transplantation: are steroids necessary?
    Padbury RT, Gunson BK, Dousset B, Hubscher SG, Mayer AD, Buckels JA, Neuberger JM, Elias E, McMaster P.
    Transpl Int; 1992 Aug 15; 5 Suppl 1():S470-2. PubMed ID: 14621849
    [Abstract] [Full Text] [Related]

  • 68. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs.
    Delucchi A, Valenzuela M, Ferrario M, Lillo AM, Guerrero JL, Rodriguez E, Cano F, Cavada G, Godoy J, Rodriguez J, Gonzalez CG, Buckel E, Contreras L.
    Pediatr Transplant; 2007 Nov 15; 11(7):743-8. PubMed ID: 17910651
    [Abstract] [Full Text] [Related]

  • 69. Cataracts after autologous bone marrow transplantation in children.
    Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G.
    Acta Paediatr; 2000 Jul 15; 89(7):814-9. PubMed ID: 10943964
    [Abstract] [Full Text] [Related]

  • 70. The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
    Slapak M, Geoghegan T, Digard N, Ahmed K, Sharman VL, Crockett R.
    Transplant Proc; 1987 Apr 15; 19(2 Suppl 2):41-5. PubMed ID: 3551255
    [No Abstract] [Full Text] [Related]

  • 71. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G.
    Transpl Int; 2005 Jan 15; 18(1):36-42. PubMed ID: 15612981
    [Abstract] [Full Text] [Related]

  • 72. Impact of the addition of maintenance steroids to a rapid steroid discontinuation immunosuppressive protocol following acute renal transplant rejection.
    Arora S, Marcus RJ, Dikkala S, Sureshkumar KK.
    Exp Clin Transplant; 2009 Dec 15; 7(4):233-6. PubMed ID: 20353373
    [Abstract] [Full Text] [Related]

  • 73. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.
    Umber A, Killackey M, Paramesh A, Liu Y, Qin H, Atiq M, Lee B, Alper AB, Simon E, Buell J, Zhang R.
    J Nephrol; 2017 Apr 15; 30(2):289-295. PubMed ID: 27062485
    [Abstract] [Full Text] [Related]

  • 74. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome.
    Opelz G.
    Transplantation; 1994 Aug 27; 58(4):443-6. PubMed ID: 8073513
    [Abstract] [Full Text] [Related]

  • 75. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.
    Klaus G, Jeck N, Konrad M, Förster B, Soergel M.
    Clin Nephrol; 2001 Dec 27; 56(6):S37-42. PubMed ID: 11770812
    [Abstract] [Full Text] [Related]

  • 76. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
    Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG.
    Transplantation; 2000 Jan 27; 69(2):307-11. PubMed ID: 10670644
    [Abstract] [Full Text] [Related]

  • 77. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
    Rajab A, Pelletier RP, Henry ML, Ferguson RM.
    Clin Transplant; 2006 Jan 27; 20(5):537-46. PubMed ID: 16968478
    [Abstract] [Full Text] [Related]

  • 78. A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants.
    Flechner SM, Goldfarb DA, Fairchild R, Modlin CS, Fisher R, Mastroianni B, Boparai N, O'Malley KJ, Cook DJ, Novick AC.
    Transplantation; 2000 Jun 15; 69(11):2374-81. PubMed ID: 10868643
    [Abstract] [Full Text] [Related]

  • 79. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
    Griño JM, Alsina J, Sabater R, Castelao AM, Gil-Vernet S, Andres E, Sabate I, Mestre M, Seron D, Diaz C.
    Transplantation; 1990 Jun 15; 49(6):1114-7. PubMed ID: 2360253
    [Abstract] [Full Text] [Related]

  • 80. Steroid withdrawal after renal transplantation: a retrospective cohort study.
    Haller MC, Kammer M, Kainz A, Baer HJ, Heinze G, Oberbauer R.
    BMC Med; 2017 Jan 12; 15(1):8. PubMed ID: 28077142
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.